2024 White Paper | 2024 Annual Meeting | Enhancing Study Designs and Interpretation of Interim Overall Survival Data in Oncology Trial Read more
2024 White Paper | 2024 Annual Meeting | Framework for Integrating Change in ctDNA Levels in Advanced Cancer Clinical Trials to Support Meta-analyses for Intermediate Endpoint Validation Read more
2024 Discussion Document | Improving Equity in Oncology Clinical Trials: Challenges and Strategies for Setting Diversity Enrollment Goals Read more
2023 White Paper | 2023 Annual Meeting | Interpreting Data from Dose-Finding Studies in Early Phase Oncology Trials to Determine the Optimal Dose Read more
2023 White Paper | Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials Read more
2023 White Paper | 2023 Annual Meeting | Maximizing Data from Academic-Led Studies for Regulatory Decision-Making Read more
2023 White Paper | 2023 Annual Meeting | Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials Read more
2023 White Paper | Considerations for Leveraging Real-World Endpoints in Oncology Drug Development Read more
